Hereditary angioedema (HAE) is a rare autosomal dominant condition characterized by episodes of swollen of the upper airway, intestines, and skin. The primary pathogenesis is the reduction in the function and/or plasma concentration of complement 1 esterase inhibitor (C1-INH). When edema involves the gastrointestinal tract, abdominal pain will be the main manifestation, which is often difficult to differentiate from surgical acute abdomen and may lead to misdiagnose and mistreatment. This paper reported a case of HAE with recurrent abdominal pain as the main manifestation, which diagnostic course was rugged and complicated. Eventually, the diagnosis was confirmed by testing the function and concentration of C1-INH, and a satisfactory clinical outcome was achieved after prophylactic treatment with Lanndelumab.
1.Busse PJ, Christiansen SC. Hereditary angioedema[J]. N Engl J Med, 2020, 382(12): 1136-1148. DOI: 10.1056/NEJMra1808012.
2.Banerjee A, Bermudez N, Gould MB, et al. Hereditary angioedema[J]. Cureus, 2023, 15(7): e42088. DOI: 10.7759/cureus.42088.
3.Henao MP, Kraschnewski JL, Kelbel T, et al. Diagnosis and screening of patients with hereditary angioedema in primary care[J]. Ther Clin Risk Manag, 2016, 12: 701-711. DOI: 10.2147/tcrm.S86293.
4.Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course[J]. Am J Med, 2006, 119(3): 267-274. DOI: 10.1016/j.amjmed.2005.09.064.
5.Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update[J]. Allergy, 2022, 77(7): 1961-1990. DOI: 10.1111/all.15214.
6.Wilkerson RG, Moellman JJ. Hereditary angioedema[J]. Emerg Med Clin North Am, 2022, 40(1): 99-118. DOI: 10.1016/j.emc.2021.09.002.
7.Xu YY, Jiang Y, Zhi YX, et al. Clinical features of hereditary angioedema in Chinese patients: new findings and differences from other populations[J]. Eur J Dermatol, 2013, 23(4): 500-504. DOI: 10.1684/ejd.2013.2105.
8.Bernstein JA. Severity of hereditary angioedema, prevalence, and diagnostic considerations[J]. Am J Manag Care, 2018, 24(14 Suppl): S292-S298. https://pubmed.ncbi.nlm.nih.gov/30132643/.
9.Tachdjian R, Banerji A, Guyer A, et al. Current characteristics associated with hereditary angioedema attacks and treatment: the home infusion based patient experience[J]. Allergy Asthma Proc, 2015, 36(2): 151-159. DOI: 10.2500/aap.2015.36.3832.
10.Staller K, Lembo A, Banerji A, et al. Consider hereditary angioedema in the differential diagnosis for unexplained recurring abdominal pain[J]. J Clin Gastroenterol, 2022, 56(9): 740-747. DOI: 10.1097/mcg.0000000000001744.
11.Rubinstein E, Stolz LE, Sheffer AL, et al. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency[J]. BMC Gastroenterol, 2014, 14: 71. DOI: 10.1186/1471-230x-14-71.
12.Cao Y, Liu S, Zhi Y. Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema[J]. Allergy Asthma Proc, 2021, 42(2): 131-135. DOI: 10.2500/aap.2021.42.210001.
13.Bork K, Staubach P, Eckardt AJ, et al. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency[J]. Am J Gastroenterol, 2006, 101(3): 619-627. DOI: 10.1111/j.1572-0241.2006.00492.x.
14.Nzeako UC, Longhurst HJ. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema[J]. Eur J Gastroenterol Hepatol, 2012, 24(4): 353-361. DOI: 10.1097/MEG.0b013e3283517998.
15.Jalaj S, Scolapio JS. Gastrointestinal manifestations, diagnosis, and management of hereditary angioedema[J]. J Clin Gastroenterol, 2013, 47(10): 817-823. DOI: 10.1097/MCG.0b013e31829e7edf.
16.Patel N, Suarez LD, Kapur S, et al. Hereditary angioedema and gastrointestinal complications: an extensive review of the literature[J]. Case Reports Immunol, 2015, 2015: 925861. DOI: 10.1155/2015/925861.
17.Geng B, Riedl MA. HAE update: special considerations in the female patient with hereditary angioedema[J]. Allergy Asthma Proc, 2013, 34(1): 13-18. DOI: 10.2500/aap.2013.34.3635.
18.Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians[J]. Arch Intern Med, 2001, 161(20): 2417-2429. DOI: 10.1001/archinte.161.20.2417.
19.Zanichelli A, Magerl M, Longhurst H, et al. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe[J]. Allergy Asthma Clin Immunol, 2013, 9(1): 29. DOI: 10.1186/1710-1492-9-29.
20.Christiansen SC, Davis DK, Castaldo AJ, et al. Pediatric hereditary angioedema: onset, diagnostic delay, and disease severity[J]. Clin Pediatr (Phila), 2016, 55(10): 935-942. DOI: 10.1177/0009922815616886.
21.Cui Q, Xu Q, Yang Y, et al. The prevalence of hereditary angioedema in a Chinese cohort with decreased complement 4 levels[J]. World Allergy Organ J, 2022, 15(1): 100620. DOI: 10.1016/j.waojou.2021.100620.
22.Bork K, Davis-Lorton M. Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management[J]. Eur Ann Allergy Clin Immunol, 2013, 45(1): 7-16. https://pubmed.ncbi.nlm.nih.gov/23678554/.
23.Valerieva A, Longhurst HJ. Treatment of hereditary angioedema-single or multiple pathways to the rescue[J]. Front Allergy, 2022, 3: 952233. DOI: 10.3389/falgy.2022. 952233.